Gene · 9101
Papers1,448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,448
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP19 deubiquitinase inactivation regulates α-synuclein ubiquitination and inhibits accumulation of Lewy body-like aggregates in mice. | NPJ Parkinsons Dis | 2023 | 38017009 | PubTator, text mining | PubMed |
Selection of Mexican Medicinal Plants by Identification of Potential Phytochemicals with Anti-Aging, Anti-Inflammatory, and Anti-Oxidant Properties through Network Analysis and Chemoinformatic Screening. | Biomolecules | 2023 | 38002355 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. | J Exp Clin Cancer Res | 2023 | 38001512 | PubTator, text mining | PubMed |
| Polymorphic USP8 allele promotes Parkinson's disease by inducing the accumulation of α-synuclein through deubiquitination. | Cell Mol Life Sci | 2023 | 37981592 | PubTator, text mining | PubMed |
| Mosquito-borne flaviviruses and type I interferon: catch me if you can! | Front Microbiol | 2023 | 37965539 | PubTator, text mining | PubMed |
| Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways. | Int J Mol Sci | 2023 | 37958702 | PubTator, text mining | PubMed |
| UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis. | Cell Death Dis | 2023 | 37957138 | PubTator, text mining | PubMed |
| Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinoma. | Eur J Med Res | 2023 | 37936239 | PubTator, text mining | PubMed |
| Functionalized Gold Nanoparticles Suppress the Proliferation of Human Lung Alveolar Adenocarcinoma Cells by Deubiquitinating Enzymes Inhibition. | ACS Omega | 2023 | 37929120 | PubTator, text mining | PubMed |
| Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease. | Arch Med Res | 2023 | 37925320 | PubTator, text mining | PubMed |
Genome Sequencing of Consanguineous Family Implicates Ubiquitin-Specific Protease 53 (USP53) Variant in Psychosis/Schizophrenia: Wild-Type Expression in Murine Hippocampal CA 1-3 and Granular Dentate with AMPA Synapse Interactions. | Genes (Basel) | 2023 | 37895270 | PubTator, text mining | PubMed |
| Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead. | Int J Mol Sci | 2023 | 37894928 | PubTator, text mining | PubMed |
| DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. | Biomolecules | 2023 | 37892185 | PubTator, text mining | PubMed |
| Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach. | Brain Sci | 2023 | 37891841 | PubTator, text mining | PubMed |
| Deubiquitylating Enzymes in Cancer and Immunity. | Adv Sci (Weinh) | 2023 | 37888853 | PubTator, text mining | PubMed |
| USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. | PLoS One | 2023 | 37874827 | PubTator, text mining | PubMed |
| Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. | Adv Sci (Weinh) | 2023 | 37867237 | PubTator, text mining | PubMed |
| An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses. | J Biol Chem | 2023 | 37865315 | PubTator, text mining | PubMed |
| Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma. | Biochem Biophys Res Commun | 2023 | 37844446 | PubTator, text mining | PubMed |
| Thrombotic Alterations under Perinatal Hypoxic Conditions: HIF and Other Hypoxic Markers. | Int J Mol Sci | 2023 | 37833987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9101/papers?page=10